News

NIIMBL Product Image
NIIMBL
Biopharmaceutical, COVID-19
NIST Awards $8.9 Million to Fund High-Impact Biopharmaceutical Manufacturing Projects to Battle COVID-19

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded $8.9 million for high-impact biopharmaceutical manufacturing projects to support the nation’s response to the COVID-19 pandemic. Authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act signed by President Donald Trump in March...

ARM WFD
AIM Photonics, America Makes, ARM, BioFabUSA, IACMI, MxD, NextFlex, NIIMBL, RAPID
Additive Manufacturing, Biopharmaceutical, Digital Manufacturing, Education, Flexible Hybrid Electronics, Photonics, Process Intensification, Recycling, Robotics, Workforce
ARM Institute Receives Funding from Office of Naval Research for Workforce Education

The Advanced Robotics for Manufacturing (ARM) Institute, through a partnership with its fellow Manufacturing USA® Institutes and led by Nextflex®, has been awarded funding from the Office of Naval Research for new manufacturing workforce education activities. The ARM Institute has partnered with Pittsburgh-based members, New Century Careers and...

NIIMBL Institute
NIIMBL
Biopharmaceutical
NIIMBL Announces $10M in New Project Funding

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, is pleased to announce funding for 14 new projects in technology, workforce development, and in their Global Health Fund initiative, resulting from the Institute’s Project Call 3.1, and with a total value of approximately $10M.

“New...

External News

Biopharmaceutical
Streamlining Buffer Management To Enable Facility Flexibility

The last decade in biopharmaceutical manufacturing has brought a considerable amount of change to how drugs are developed and manufactured. Advances in science and technology have resulted in more diversified pipelines with increasingly complex molecules. Seeking faster ways to bring novel drugs to market while meeting stringent product quality...

HuffPost
Biopharmaceutical, COVID-19
Why It Takes So Long To Make A Coronavirus Vaccine

As of the end of April, the World Health Organization was tracking 71 coronavirus vaccines in preclinical trials, with five additional candidates already in clinical trials. Given how recently the COVID-19 pandemic began spreading, it might seem promising that there’s already a lot of activity on the immunization front.

With so many potential...

Our Network @ Work